Research
AI-discovered drug rentosertib enters Phase III trial
Rentosertib, an AI-discovered TNIK inhibitor for IPF, enters Phase III with 320 patients. It is the first fully AI-originated drug to reach late-stage trials.
#drug discovery
3 stories tagged drug discovery.
Business
Anthropic drug discovery hits the wet-lab wall
Anthropic drug discovery pushes Claude Science into pharma R&D, but wet-lab costs and data gaps mean no AI-designed drug has cleared FDA approval yet.
AI
Claude Science turns lab agents into pharma plumbing
Anthropic's Claude Science beta workbench ships 60-plus curated skills and connectors for researchers. Treat it as lab infrastructure first.